Full Text View
Tabular View
No Study Results Posted
Related Studies
Orlistat Treatment of Crigler-Najjar Disease
This study has been completed.
Study NCT00461799   Information provided by University Medical Centre Groningen
First Received: April 16, 2007   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Crigler-Najjar Syndrome
Additional conditions recognized in this trial
Hyperbilirubinemia
Syndrome
More general conditions related to this trial
Disease
Genetic Diseases, Inborn
Hyperbilirubinemia, Hereditary
Metabolic Diseases
Metabolism, Inborn Errors
Pathologic Processes
Interventions listed in this trial
orlistat
More general drug interventions related to this trial
Anti-Obesity Agents
Central Nervous System Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University Medical Centre Groningen
Erasmus Medical Center
De Najjar Stichting


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services